Latest Blog Posts Tagged "Clinician"
March 28, 2019
At MJFF's course for neurology doctors in training, attendees learned about Parkinson's and other movement disorders from patients and world-renowned experts.
March 18, 2019
A recent graduate of The Edmond J. Safra Fellowship in Movement Disorders, Dr. David Breen is now using his specialized training to bridge the divide between Parkinson's research and care in the UK.
September 25, 2018
Dystonia can be a symptom of Parkinson's or a complication of treatment. It can also be a disease by itself, affecting up to two percent of professional musicians.
December 08, 2016
Voyager Therapeutics announced results from a trial, supported in early stages by MJFF, to help the brain convert levodopa to dopamine and better control motor symptoms.
December 01, 2016
Two recently published studies, one MJFF-funded, point to mutations in the GBA gene that may predispose some to cognitive problems with Parkinson's disease.
October 05, 2016
The Michael J. Fox Foundation has piloted efforts to educate busy practicing clinicians about ongoing research and ways in which they can partner with their patients to get involved.
September 21, 2016
A new formulation of amantadine to better treat levodopa-induced dyskinesia is entering the home stretch.
September 07, 2016
Austrian biotech AFFiRiS reports a boost dose of its vaccine against key protein alpha-synuclein is safe and elicits antibodies. MJFF funded the trial.
July 12, 2016
Today MJFF, the Van Andel Research Institute and the Cure Parkinson's Trust announced plans to collaborate to assess the clinical use and development of cancer drug nilotinib.
May 31, 2016
Nuplazid, a drug indicated for the treatment of Parkinson's disease psychosis, is now available for prescription.